Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network

医学 四分位间距 危险系数 阶段(地层学) 内科学 回顾性队列研究 置信区间 比例危险模型 癌症 甲状腺癌 甲状腺 多中心研究 放射治疗 肿瘤科 外科 随机对照试验 古生物学 生物
作者
Arnaud Jannin,Fabiola Giudici,Christelle De La Fouchardière,Abir Al Ghuzlan,Johanna Wassermann,C. Chougnet,D. Drui,Yann Godbert,Frédéric Ilouz,Stéphane Bardet,Sylvie Zanetta,N. Roudaut,Marie Batisse Lignier,Lionel Groussin,Marc Klein,Slimane Zerdoud,Livia Lamartina,Éric Baudin,Myriam Decaussin‐Petrucci,Emmanuelle Leteurtre
出处
期刊:Thyroid [Mary Ann Liebert, Inc.]
卷期号:33 (10): 1190-1200 被引量:12
标识
DOI:10.1089/thy.2023.0164
摘要

Background: Anaplastic thyroid carcinoma (ATC) is a rare and frequently fatal type of thyroid cancer. The degree of heterogeneity in survival rates for ATC is incompletely studied. This study evaluated the factors associated with overall survival (OS) of patients with ATC using multicenter real-world data from a national tertiary care center network in France. Methods: In this multicenter, retrospective cohort study, all patients with ATC diagnosed between 2010 and 2020 were identified from the national database of the French ENDOCAN-TUTHYREF network. Factors associated with OS were examined in multivariable analyses using Cox proportional hazards models. Results: The study included 360 patients. Of these, 220 (61%) were female and the median age was 72 years (interquartile range: 62–80). The percentages of patients with pure and mixed (synchronously-transformed) ATC (p-ATC and st-ATC) were 62.5% and 26.7%, respectively. The median OS was 6.8 months [confidence interval, CI: 5.5–8.1]: not reached for stage IVa, 11.4 months [8.2–17.8] for IVb, and 4.6 months [3.5–5.7] for IVc. Surgery, radiation therapy to the neck, chemotherapy, and best supportive care were administered to 69 (19.2%), 214 (59.4%), 254 (70.6%), and 66 (18.3%) patients, respectively. In a multivariable analysis, including stage IVb–IVc patients, significantly higher OS was observed in patients with Eastern Cooperative Oncology Group performance-status of 0–1 (hazard ratio [HR], 0.6; [CI, 0.4–0.9], p < 0.02), stage IVb [HR, 0.5; CI, 0.4–0.8, p < 0.001], and multimodal treatment (surgery and chemoradiotherapy) [HR, 0.07; CI, 0.04–0.1, p < 0.001]. Variables associated with significantly worse OS included: p-ATC (vs. st-ATC) [HR, 1.83; CI, 1.33–2.51, p = 0.001] and a neutrophil-to-lymphocyte ratio (NLR) >5.05 [HR, 2.05, CI, 1.39–3.05, p < 0.001]. Conclusions: Factors independently associated with improved OS in ATC included: European Cooperative Oncology Group performance status, disease stage, multimodality treatment, synchronously transformed ATC, and lower NLR. Long-term OS was observed in selected patients with ATC who underwent multimodal treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
蓝色的纪念完成签到,获得积分10
1秒前
4秒前
yar应助kk采纳,获得10
4秒前
6秒前
6秒前
明理的蜗牛完成签到,获得积分10
6秒前
zj完成签到 ,获得积分10
7秒前
10秒前
林宝雯发布了新的文献求助10
10秒前
Xylah_Rebecca发布了新的文献求助10
11秒前
15秒前
思源应助lh23采纳,获得10
15秒前
西川完成签到 ,获得积分10
16秒前
17秒前
脑洞疼应助a雪橙采纳,获得10
18秒前
19秒前
20秒前
yydragen应助给他来个地瓜采纳,获得30
21秒前
宋璐宏完成签到,获得积分10
21秒前
zzz发布了新的文献求助10
23秒前
扶桑完成签到,获得积分10
23秒前
Liufgui应助七七采纳,获得10
23秒前
敏感板栗完成签到,获得积分10
25秒前
大个应助Ren采纳,获得10
25秒前
zjw发布了新的文献求助10
25秒前
宋璐宏发布了新的文献求助10
25秒前
SciGPT应助hufan2441采纳,获得10
28秒前
30秒前
30秒前
JamesPei应助810采纳,获得30
30秒前
janie发布了新的文献求助10
33秒前
乱武发布了新的文献求助10
33秒前
安静的思远完成签到,获得积分20
33秒前
少爷发布了新的文献求助10
33秒前
深情安青应助QYPANG采纳,获得10
33秒前
34秒前
36秒前
39秒前
wpx发布了新的文献求助10
39秒前
39秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989711
求助须知:如何正确求助?哪些是违规求助? 3531864
关于积分的说明 11255235
捐赠科研通 3270505
什么是DOI,文献DOI怎么找? 1804983
邀请新用户注册赠送积分活动 882157
科研通“疑难数据库(出版商)”最低求助积分说明 809176